New Delhi, February 15, 2018: Indonesia Healthcare market segment by hospital, pharmaceutical, pharmacy retail, clinical laboratory and medical devices, hospital market segment (by public & private hospitals, by general & specialty hospitals and by region), pharmaceutical market segment (by therapeutic segment, by domestic & international players, by generic & patented drug, by OTC & prescription drugs, by domestic sales & exports and by region), pharmacy retail market segment (by pharmacies & drugstores and by region), clinical laboratory market segment (by type of clinical laboratory, by type of private independent laboratory, by type of customer, by payer, by type of test and by region) and medical device market segment (by type of medical device, by type of medical consumables, by end user and by procurement), competitive landscape of major players in the Indonesia hospital, pharmaceutical, pharmacy retail, clinical laboratory and medical devices market and covering company profile of major Hospitals (Mitra Keluarga Karyasehat Tbk Pt, Siloam Hospitals, PT Sejahteraraya Anugrahjaya, Sarana Meditama, Rumah Sakit Pondok Indah, Surya Husadha, Jakarta Eye Center), pharmaceutical companies (PT Kalbe Farma, PT Sanbe Farma, PT SOHO Global Health, PT Dexa Medica, PT Pharos, PT Kimia Farma, PT Tempo Scan Pacific, PT Merck), Pharmacy Retail (Guardian Pharmacy, Kimia Farma, Apotek K-24, A S Watsons, Century Healthcare), Diagnostic Laboratories (Prodia, Kimia Farma Diagnostika, Pramita, Cito, BioMedika, Parahita), Medical Devices Companies (GE Healthcare Indonesia, Siemens Indonesia, Philips Indonesia, PT Mensa Binasukses, PT Transmedic Indonesia)
The healthcare market in Indonesia was majorly impacted by the implementation of JKN (The Indonesian National Health Insurance) as the demand for affordable/ primary healthcare services, generic medicines and import of medical devices increased.
Indonesia pharmaceutical market is dominated by domestic players such as PT Kalbe Farma, PT Sanbe Farma, PT SOHO Global Health and others. The Indonesia Medical device market is almost entirely import driven due to limited manufacturing capabilities in Indonesia.
Siloam Hospitals has the largest hospital network in the country. Public sector hospital has the larger share in terms of number of hospitals in 2017.
Indonesia Healthcare market will be facilitated by the rising number of healthcare providers coupled with elevating prevalence of chronic diseases such as diabetes, HIV, Tuberculosis and others. More than 35,000 new beds are likely to be added in Indonesia by 2020. Moreover, due to the entry of new participants into the private hospital market and expansion of existing ones, the country is expected to achieve 1.5 beds per 1,000 people by 2019.
Single specialty or multi-specialty hospitals in the country are planning to invest in advanced medical devices to provide tertiary or super specialty treatment to the patients. For instance, Mandaya Hospital expects to see sharp revenue growth: 30.0% y-o-y rise in 2018 as the hospital will invest in new equipment that should boost demand.
In the long term, the pharmaceutical industry will witness an increase in demand for nutrition and micronutrient supplements due to growing prevalence of lifestyle diseases such as obesity and malnutrition. Apart from manufacturing generic and patented drugs, pharmaceutical companies will shift focus to other niche segments such as combined dosages, novel drug delivery areas. Further, Indonesia pharmaceutical market is expected to grow in future with increasing ageing population, growth in health care expenditure and increasing lifestyle related diseases.
The major pharmacy chains in the country are expected to launch various mobile applications and online retail services thus increasing accessibility and convenience of home delivery and online payment facility. The online stores will adopt omni-channel mode of expansion with strong expansion of brick and mortar stores in order to support online sales by reducing delivery time and improving accessibility
The clinical laboratory market is expected to increase 1.5 times by 2022 supported by higher growth in esoteric tests segment. Further, the industry will witness a rising trend towards precision medicine also known as personalized medicine. Growth in the availability of testing equipment that can be operated locally and that does not require free-standing clinical laboratories and advancements in self-testing kits that can be operated by customers themselves can result in a decrease in the volume of tests at laboratories.
Increased focus on research and development for pharmaceutical products, medical devices and laboratory services coupled with elevating prevalence of chronic and lifestyle diseases will propel the Indonesia healthcare market revenue in future.
Ken Research in its latest study, “Indonesia Healthcare Market Outlook to 2022 – by Hospitals, Clinical Laboratories, Pharmaceutical, Pharmacy Chains, Medical Device Segment”, suggested that demand for healthcare services in the market will continue to grow in Indonesia owing to favorable government regulations for FDI inflows, rising prominence of health tech startups, increased focus on biopharmaceuticals and nutrition and dietary supplements.
Key Topics Covered in the Report:
Pharmacy Retail Industry Trends Indonesia
Vitamin and Mineral Supplements Indonesia
Kalbe Farma Market Share Indonesia
Indonesia Healthcare Statistics
Polyclinic Market Indonesia
Number of Clinical Labs Prodia
Number of Pharmacies Indonesia
Medical Devices Market Indonesia
Diabetes Prevalence Indonesia
Number of Drugstore Indonesia
Healthcare Market Size Indonesia
Indonesia Healthcare Market Future
Pharmaceutical Market Indonesia
Indonesia Pharmacy Retail Market Future
Hospital Market Future Trends Indonesia
Indonesia Medical Devices Market Future
Indonesia Number of General Hospitals
Indonesia Pharmaceutical Market Future
Value Chain Clinical Laboratory market Indonesia
For more information on the research report, refer to below link:
https://www.kenresearch.com/healthcare/general-healthcare/indonesia-healthcare-market/143541-91.html
Corporate Comm India(CCI Newswire)
